| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 04/16/2003 | CN1411369A Biodegradable microparticles with novel erythropoietin stimulating protein |
| 04/16/2003 | CN1410059A Treating method and medicine kit containing somatotrophic hormone secretory agent |
| 04/15/2003 | US6548675 1-Cyclopropylcarbonyl-2-hydroxy(optional),4-isopropylbenzene used as starting materials for 1-((2-hydroxy(optional),4-alkylphenyl)carbonylalkyl-),4-(diphenylmethyl -)piperidine derivatives; antihistamines; antiallergens; bronchodilators |
| 04/15/2003 | US6548069 Multivalent Mycoplasma bacterin |
| 04/15/2003 | CA2112679C Dosage form for delivering drug in short-time period |
| 04/15/2003 | CA2108018C Colloidal particles of water insoluble biologically active substances |
| 04/10/2003 | WO2003028735A1 Estrogen/gestagen combination preparation and application thereof |
| 04/10/2003 | WO2003028717A1 A drugs association against influenza virus |
| 04/10/2003 | WO2003028634A2 Method of treatment using ligand-immunogen conjugates |
| 04/10/2003 | WO2003028527A2 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 04/10/2003 | WO2003002092A3 Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same |
| 04/10/2003 | WO2002083079A9 Aerosol compositions containing formoterol for delivery to the lungs via nebulization |
| 04/10/2003 | WO2002074238A3 Water soluble and palatable complexes |
| 04/10/2003 | US20030069526 Applicators that house and support ultrasound transducers for transcutaneous delivery of ultrasound energy |
| 04/10/2003 | US20030068388 N-benzyl-16(R,S)-hydroxy-9-oxo-10E,12E,14E-octadecatrieneamide isolated from Lepidium plant material, useful for treating and preventing cancer and sexual disorder |
| 04/10/2003 | US20030068378 Mucosal surface-coat-forming film dosage units containing a water-soluble hydrocolloid, an effective dose of a sexual dysfunction active agent and a mucosal adhesion enhancer, wherein mucosal adhesion enhancer is a starch graft copolymer |
| 04/10/2003 | US20030066525 Pressurised metered dose inhalers (MDI) |
| 04/10/2003 | CA2462075A1 Estrogen/gestagen combination preparation and application thereof |
| 04/10/2003 | CA2461877A1 Method of treatment using ligand-immunogen conjugates |
| 04/10/2003 | CA2461099A1 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 04/09/2003 | EP1300396A1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
| 04/09/2003 | EP0986580B1 Oligosaccharide mixtures having antithrombotic activity |
| 04/09/2003 | EP0956013B1 Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid |
| 04/09/2003 | EP0929290B1 Cosmetic composition |
| 04/09/2003 | EP0912191B1 Vegetable extract, method for preparation thereof and its applications in human and veterinary medicine |
| 04/09/2003 | EP0848612B1 Use of calendula glycosides for the treatment of psoriasis |
| 04/09/2003 | EP0806940B1 Aerosol drug formulations |
| 04/09/2003 | CN1409716A New amino propylphosphinic acid |
| 04/09/2003 | CN1105111C Pyrazine compounds |
| 04/09/2003 | CN1104911C Improvements in or relating to contrast agents |
| 04/09/2003 | CN1104905C Novel powder compositions |
| 04/09/2003 | CN1104904C Natural tea for taking off the offect of drink and process for production thereof |
| 04/09/2003 | CN1104900C Use of 8,9-dehydroestrone as anti-oxidant |
| 04/08/2003 | US6544998 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 04/08/2003 | US6544518 Vaccines |
| 04/08/2003 | CA2222852C Keratin fibre oxidation dye composition and dye process using the composition |
| 04/08/2003 | CA2119573C Process and kit for dyeing hair |
| 04/03/2003 | WO2003026659A1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 04/03/2003 | WO2003026584A2 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 04/03/2003 | WO2003026569A2 Composition and method for the treatment of hypercholesterolemia and hyperlipidemia in mammals |
| 04/03/2003 | WO2003002531A3 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 04/03/2003 | WO2002024909A9 Receptor nucleic acids and polypeptides |
| 04/03/2003 | US20030065038 Administering N-propargyl-1-aminoindan |
| 04/03/2003 | US20030064992 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 04/03/2003 | US20030064927 Regeneration of soft tissue; wound healing agents |
| 04/03/2003 | US20030064914 Copolymer-1 improvements in compositions of copolymers |
| 04/03/2003 | US20030064117 For oral administration, injection and topical application |
| 04/03/2003 | CA2688860A1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 04/03/2003 | CA2461861A1 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 04/02/2003 | EP1297108A2 Cell lines and cell-based assays for identification of androgen receptor modulators |
| 04/02/2003 | EP1296951A1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3']bipyridinyl in pure crystalline form and process for synthesis |
| 04/02/2003 | EP1296938A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 04/02/2003 | EP1192155B1 New bispidine compounds useful in the treatment of cardiac arrhythmias |
| 04/02/2003 | EP1000027B1 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- 2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it |
| 04/02/2003 | EP0809481B1 Novel hair relaxer compositions and method for preparing same |
| 04/02/2003 | CN1407897A DHEA composition and method |
| 04/02/2003 | CN1407895A Pharmaceutical combination of ethinylestradiol and drospirenone for use as contraceptive |
| 04/02/2003 | CN1104432C Pyrrole triazines and pyrimidine compound |
| 04/01/2003 | US6542858 Pharmacokinetic-based drug design tool and method |
| 04/01/2003 | US6541481 Substituted bicyclic derivatives useful as anticancer agents |
| 04/01/2003 | US6541425 Retarding formulations of active substances used for plant protection |
| 04/01/2003 | US6541163 Process of powder for bath from natural plants |
| 04/01/2003 | US6540986 Inorganic sunscreen agent such as titanium dioxide, an anioic emulsifier, a carrier oil and at least one emollient; high sun protection factor without whitening effects |
| 03/28/2003 | CA2405342A1 Methods of treatment and kits comprising a growth hormone secretagogue |
| 03/27/2003 | WO2003024489A2 Combination of a nsaid and a pde-4 inhibitor |
| 03/27/2003 | WO2003024444A1 Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
| 03/27/2003 | US20030060695 Implantable artificial organ devices |
| 03/27/2003 | US20030060638 C7 carbamate substituted taxanes |
| 03/27/2003 | US20030060598 Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 03/27/2003 | US20030060485 (+)-norcisapride |
| 03/27/2003 | US20030060477 Administering to a patient a betablocker and a cholesterol-lowering agent to treat atherosclerosis, hyperpoproteinemia and hypercholesterolemia |
| 03/27/2003 | US20030060400 A modified nucleoside comprising a purine or pyrimidine ring for treating viral infections |
| 03/27/2003 | US20030059487 Composition and method for the treatment of hypercholesterolemia and hyperlipidemia in mammals |
| 03/26/2003 | EP1296142A2 Calcium receptor active molecules |
| 03/26/2003 | EP1294735A2 Methods and compositions for treating flaviviruses and pestiviruses |
| 03/26/2003 | EP1294724A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 03/26/2003 | EP1294720A1 Non-nucleoside reverse transcriptase inhibitors |
| 03/26/2003 | EP1294408A1 Rhodamine diagnostic agent and diagnostic methods for detection of epithelial cancer |
| 03/26/2003 | EP1294378A2 Thrombopoietin mimetics |
| 03/26/2003 | EP1041963B1 Non-whitening underarm compositions |
| 03/26/2003 | EP1007102B1 Process for preparing contrast agents |
| 03/26/2003 | CN1404833A 药物组合物 The pharmaceutical composition of |
| 03/26/2003 | CN1103593C Synergistic composition |
| 03/25/2003 | US6538038 A method of treating a warm-blooded animal having a vascular proliferative disorder, comprising administering, to the animal, an amount of a prodrug of a tubulin binding agent, other than combretastatin A4 disodium phosphate to achieve |
| 03/25/2003 | US6538034 Methods of treating or preventing weight gain, obesity, and related disorders |
| 03/25/2003 | US6537591 Aquatic animal treatment method and composition containing Pimenta extract |
| 03/25/2003 | CA2379005A1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 03/25/2003 | CA2113908C 1-[n-(halo-3-pyridylmethyl)]-n-methylamino-1-alkylamino-2- nitroethylene derivatives for controlling fleas in domestic animals |
| 03/20/2003 | WO2003022824A1 Oxazolidinone and/or isoxazoline as antibacterial agents |
| 03/20/2003 | WO2003022286A1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| 03/20/2003 | WO2003022279A1 Inhalation compositions comprising tricyclic 5,6-dihydro-9h-pyrazolo (3,4-c)-1,2,4-triazolo (4,3-alpha) pyridines and a tiotropium salt |
| 03/20/2003 | WO2003022275A1 Inhalation compositions comprising tricyclic 5,6-dihydro-9h-pyrazolo (3,4-c)-1,2,4-triazolo (4,3-alpha) pyridines |
| 03/20/2003 | WO2003022269A1 Novel use of substituted aminomethyl chromans for the treatment of movement disorders and of adverse effects induced by drugs administered to treat extrapyramidal movement disorders |
| 03/20/2003 | WO2003022123A2 Methods of kidney transplantation utilizing developing nephric tissue |
| 03/20/2003 | WO2002102322A3 Stable cosmetic emulsion with polyamide gelling agent |
| 03/20/2003 | US20030055068 Pyrazole compounds useful as protein kinase inhibitors |
| 03/20/2003 | US20030055035 Useful in hyperpolarizing cell membranes, opening potassium channels, relaxing smooth muscle cells, and inhibiting bladder contractions |
| 03/20/2003 | US20030055024 Administering in divided doses an effective amount of a vascular damaging agent or a pharmaceutically acceptable salt thereof for production of a vascular damaging effect in a warm-blooded animal such as a human |
| 03/20/2003 | US20030055022 Treatment for reactive arthritis or bursitis |
| 03/20/2003 | US20030054047 Administering plant extract; solvent extraction |